Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000232327 | SCV000283586 | likely benign | Fanconi anemia | 2023-12-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001722206 | SCV000512962 | likely benign | not provided | 2019-06-04 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988222 | SCV001137859 | likely benign | Fanconi anemia complementation group A | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001012621 | SCV001173097 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-02-23 | criteria provided, single submitter | clinical testing | The c.166-5C>T intronic variant results from a C to T substitution 5 nucleotides upstream from coding exon 2 in the FANCC gene. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |